Search research articles
Contact Us
Filters
Showing results (211-220 of 525) with videos related to
Page
of 53
Sort By:
Plos Pathogens
|
February 28, 2015
Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses
Gemma Hancock, Hongbing Yang, Elisabeth Yorke, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2012
Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3
Krisztina M Papp-Wallace, Baui Senkfor, Julian Gatta, et al.
Journal of Virology
|
July 12, 2013
Immune focusing and enhanced neutralization induced by HIV-1 gp140 chemical cross-linking
T Schiffner, L Kong, C J A Duncan, et al.
Frontiers in Immunology
|
January 11, 2020
Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
Dieter Mielke, Gama Bandawe, Justin Pollara, et al.
Scientific Reports
|
August 5, 2020
Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature
Rohith Palli, Kelly E Seaton, Michael S Piepenbrink, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
March 18, 2022
Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and spike-transfected cells and mediate NK cell degranulation
Dieter Mielke, Sherry Stanfield-Oakley, Shalini Jha, et al.
Iscience
|
August 18, 2025
Transient regulatory T cell manipulation is limited by anti-antibody responses in HIV-1 envelope immunized rhesus macaques
Shuqin Gu, Kan Luo, Tarra A Von Holle, et al.
Journal of Virology
|
October 13, 2017
HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine
Xiaoying Shen, Rahul Basu, Sheetal Sawant, et al.
Journal of Virology
|
May 27, 2011
Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual
Elin S Gray, M Anthony Moody, Constantinos Kurt Wibmer, et al.
Plos One
|
May 25, 2012
Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum
James Friedman, S Munir Alam, Xiaoying Shen, et al.
Page
of 53
Search research articles
Search
Showing results (211-220 of 525) with videos related to
Sort By:
Page
of 53
Plos Pathogens
|
February 28, 2015
Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses
Gemma Hancock, Hongbing Yang, Elisabeth Yorke, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2012
Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3
Krisztina M Papp-Wallace, Baui Senkfor, Julian Gatta, et al.
Journal of Virology
|
July 12, 2013
Immune focusing and enhanced neutralization induced by HIV-1 gp140 chemical cross-linking
T Schiffner, L Kong, C J A Duncan, et al.
Frontiers in Immunology
|
January 11, 2020
Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
Dieter Mielke, Gama Bandawe, Justin Pollara, et al.
Scientific Reports
|
August 5, 2020
Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature
Rohith Palli, Kelly E Seaton, Michael S Piepenbrink, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
March 18, 2022
Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and spike-transfected cells and mediate NK cell degranulation
Dieter Mielke, Sherry Stanfield-Oakley, Shalini Jha, et al.
Iscience
|
August 18, 2025
Transient regulatory T cell manipulation is limited by anti-antibody responses in HIV-1 envelope immunized rhesus macaques
Shuqin Gu, Kan Luo, Tarra A Von Holle, et al.
Journal of Virology
|
October 13, 2017
HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine
Xiaoying Shen, Rahul Basu, Sheetal Sawant, et al.
Journal of Virology
|
May 27, 2011
Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual
Elin S Gray, M Anthony Moody, Constantinos Kurt Wibmer, et al.
Plos One
|
May 25, 2012
Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum
James Friedman, S Munir Alam, Xiaoying Shen, et al.
Page
of 53